Pharma quality issues - need prevention-driven regulatory culture: Dr. M. Aamir Mirza Wednesday, December 3, 2025, 08:00 Hrs [IST] The concerns surrounding the quality of pharmace ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the latest data confirming the pharmacological effect of lecanemab (generic name, U.S. brand name: ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈